Landmark China trial gets 84% efficacy in treating cancer with cue from waste water tech

China

What to know

  • For patients with advanced, metastatic cancer that has progressed despite systemic therapy – options remain critically limited. Now, Chinese scientistsS1
  • For patients with advanced, metastatic cancer that has progressed despite systemic therapy – options remain critically limited. Now, Chinese scientists are pointing to an unconventional therapeutic agent – the element iron. This idea originated in industrial w...S2
Timeline · newest first
1w Wol

Landmark China trial gets 84% efficacy in treating cancer with cue from waste water tech

For patients with advanced, metastatic cancer that has progressed despite systemic therapy – options remain critically limited. Now, Chinese scientists

1w Scmp

Landmark China trial gets 84% efficacy in treating cancer with cue from waste water tech

For patients with advanced, metastatic cancer that has progressed despite systemic therapy – options remain critically limited. Now, Chinese scientists are pointing to an unconvent…

Landmark China trial gets 84% efficacy in treating cancer with cue from waste water tech

2 outlets 2 reports

What to know

  • For patients with advanced, metastatic cancer that has progressed despite systemic therapy – options remain critically limited. Now, Chinese scientistsS1
  • For patients with advanced, metastatic cancer that has progressed despite systemic therapy – options remain critically limited. Now, Chinese scientists are pointing to an unconventional therapeutic agent – the element iron. This idea originated in industrial w...S2
Timeline · newest first

Sources · 2 citations

S1 Wol 1 report · EN
S2 ScmpLead 1 report · EN